Wellington Management Group’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-779,559
Closed -$138M 2049
2020
Q1
$138M Sell
779,559
-57,275
-7% -$10.8M 0.04% 390
2019
Q4
$160M Sell
836,834
-872,202
-51% -$157M 0.03% 456
2019
Q3
$288M Sell
1,709,036
-21,083,760
-93% -$3.43B 0.06% 288
2019
Q2
$3.82B Sell
22,792,796
-1,859,004
-8% -$257M 0.84% 20
2019
Q1
$3.61B Sell
24,651,800
-282,159
-1% -$40.9M 0.82% 23
2018
Q4
$3.33B Buy
24,933,959
+2,480,031
+11% +$407M 0.83% 20
2018
Q3
$4.28B Buy
22,453,928
+461,570
+2% +$84.8M 0.9% 14
2018
Q2
$3.67B Buy
21,992,358
+319,806
+1% +$51.3M 0.82% 18
2018
Q1
$3.65B Buy
21,672,552
+177,672
+0.8% +$29.8M 0.83% 17
2017
Q4
$3.52B Buy
21,494,880
+1,877,004
+10% +$337M 0.78% 20
2017
Q3
$4.02B Sell
19,617,876
-1,086,961
-5% -$253M 0.92% 13
2017
Q2
$5.03B Sell
20,704,837
-851,105
-4% -$200M 1.19% 8
2017
Q1
$5.15B Sell
21,555,942
-1,130,455
-5% -$263M 1.24% 9
2016
Q4
$4.76B Sell
22,686,397
-1,469,528
-6% -$304M 1.2% 9
2016
Q3
$5.56B Buy
24,155,925
+273,953
+1% +$66.9M 1.39% 6
2016
Q2
$5.52B Buy
23,881,972
+3,110,863
+15% +$717M 1.43% 7
2016
Q1
$5.57B Sell
20,771,109
-503,620
-2% -$144M 1.47% 6
2015
Q4
$6.65B Buy
21,274,729
+3,396,092
+19% +$1.01B 1.74% 5
2015
Q3
$4.86B Buy
17,878,637
+587,613
+3% +$180M 1.35% 7
2015
Q2
$5.25B Sell
17,291,024
-678,457
-4% -$202M 1.35% 7
2015
Q1
$5.35B Buy
17,969,481
+2,190,873
+14% +$625M 1.38% 7
2014
Q4
$4.06B Buy
15,778,608
+811,223
+5% +$203M 1.07% 13
2014
Q3
$3.61B Buy
14,967,385
+6,495,508
+77% +$1.45B 1% 15
2014
Q2
$1.89B Buy
8,471,877
+718,957
+9% +$149M 0.51% 41
2014
Q1
$1.6B Buy
7,752,920
+2,264,246
+41% +$448M 0.44% 50
2013
Q4
$922M Buy
5,488,674
+850,086
+18% +$133M 0.27% 86
2013
Q3
$668M Buy
4,638,588
+188,562
+4% +$25.1M 0.21% 106
2013
Q2
$562M Buy
+4,450,026
New +$504M 0.18% 114

Other funds holding AGN

Wellington Management Group's AGN Position: Q2 2020 in Review

Wellington Management Group sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 779,559 shares — an estimated $138M sold.

Wellington Management Group first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $6.65B in Q4 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Wellington Management Group reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Wellington Management Group sold 779,559 Allergan plc shares in Q2 2020, an estimated $138M.
  • Wellington Management Group first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
  • Wellington Management Group's Allergan plc position peaked at $6.65B in Q4 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Wellington Management Group's 13F filing for Q2 2020, filed 14 Aug 2020.